7 Jul

Eli Lilly and Company: A US Pharmaceutical Company

WRITTEN BY Mike Benson

Company overview

Eli Lilly and Company (LLY), also referred to as “Lilly,” is a US pharmaceutical company headquartered in Indianapolis, Indiana. Lilly deals with both human pharmaceuticals and animal health. For human pharmaceuticals, the company deals in various therapeutic areas including bone muscle joints, cardiovascular, diabetes, endocrine, men’s health, neuroscience, and oncology.

Elanco is a division of Lilly that deals with animal health. In animal health, the company deals with protein production, companion animal health, and food safety. Lilly has its manufacturing plants in 13 countries. Its products are marketed in over 120 countries.

Eli Lilly and Company: A US Pharmaceutical Company

Share price performance

The above graph shows the share price performance of Lilly compared to its peers. On an annualized basis, Lilly has delivered returns of 17.9% from July 2010 to June 2015. This is higher than a few of its peers like Merck and Company (MRK), Bristol-Myers Squibb (BMY), Novartis AG (NVS), and Pfizer (PFE). They delivered annual returns of 11.2%, 22.2%, 15.6%, and 19%, respectively. During the same period, the annualized return for the Health Care Select Sector SPDR ETF (XLV) was 22.1%.

History

Eli Lilly and Company was founded in May 1876 by Colonel Eli Lilly in Indianapolis, Indiana. During the 1880s, Lilly was one of the first companies to initiate a bonafide pharmaceutical research program. In 1886, Ernest G. Eberhardt joined the company as its first full-time research scientist.

In 1950, Lilly began Tippecanoe Laboratories in Lafayette, Indiana. It increased the production of antibiotics. In 1954, Lilly formed Elanco Products Company for the production of veterinary pharmaceuticals. In 1962, Lilly established a factory in Liverpool, England, with an acquisition from Distillers Company. In 1977, Lilly ventured into the medical instruments segment with the acquisition of IVAC. Other acquisitions include Cardiac Pacemakers in 1977, Physio-Control Corporation in 1980, Advance Cardiovascular Systems in 1984, Hybritech in 1986, Vascular Intervention in 1989, and Pacific Biotech in 1990.

Today, the company has ~41,290 employees in operations throughout the world.

Latest articles

Pinduoduo (PDD) stock fell more than 20% in early trading today. The Chinese e-commerce stock is trading at $32.50, 28% below its 52-week high.

On November 19, Microsoft declared that Teams, its workplace chat app, had over 20 million daily active users, more than a 50% surge from July.

Despite the turmoil in the cannabis industry, Organigram (OGI) stock has been soaring. OGI closed up 12.6% yesterday ahead of its Q4 earnings.

The partial trade deal between the US and China may just have hit a new snag. Yesterday, the US Senate passed a Hong Kong Human Rights bill.

Yesterday, Macy’s (M) stock fell 10.9% after department store peer Kohl’s (KSS) announced weak third-quarter results and shared a gloomy outlook.

Last week, T-Mobile stated that if its merger with Sprint goes through, it will create a new Customer Experience Center in Nassau County, New York.